No known gene mutations: After being... - Advanced Prostate...

Advanced Prostate Cancer

22,371 members28,137 posts

No known gene mutations

Cynthgob profile image
8 Replies

After being tested there are no known gene mutations in my husband’s DNA. All mutations were checked that are known to attribute to prostate cancer. My question : is it a good thing or a bad thing? I know it’s good for my family but is it for my husband in that if you have a gene mutation doesn’t it make it easier to attack the specific cancer you have? Isn’t the new lymparza study targeting dna mutations? Just wondering? Thank you!!

Written by
Cynthgob profile image
Cynthgob
To view profiles and participate in discussions please or .
Read more about...
8 Replies
Cynthgob profile image
Cynthgob

There’s a lot I don’t know about my husbands specific cancer. All I know is it’s spread to lymph nodes and most of skeletal. Not in organs.

ctarleton profile image
ctarleton

Interesting question. Lynparza (olaparib) is what is called a PARP inhibitor. Sometimes in people with various cancers, and specific inherited mutations (e.g. BRCA-2), they try using it to see if they can get the more rapidly-growing cancer cells which may have damaged DNA to die off at a faster rate than normal cells. However, roughly 90% of men with prostate cancer don't have any of the few kinds of inherited mutations like this.

(Personally, I'd rather not have a mutation such as BRCA-2, or whatever, which allows sporadic DNA damage in my cells to go unrepaired at the same time that my body is already dealing with advanced prostate cancer and various other treatments.)

For anybody here who may actually have one of these inherited mutations, here's a link that provides an update on research and progress in the field. Table 2 provides information about several single agent PARP inhibitors clinical trials in progress.

"ASCO 2018: Optimal Integration of PARP Inhibitors for Prostate Cancer: Which Test, Which Patient, and Which Therapy?"

urotoday.com/conference-hig...

Charles

Cynthgob profile image
Cynthgob in reply toctarleton

Thank u!

Tall_Allen profile image
Tall_Allen

It's a good thing. Germline mutations in DNA-repair genes allow more aggressive cancers to proliferate. In a recent Phase 2 study, there was no difference in response in men who took a PARP inhibitor whether they had a DNA repair mutation or not.

Kat95 profile image
Kat95

My husband has a somatic (non genetic) brca2 mutation - PARP inhibitors didn’t help. They’re marketed as the new big thing but did zilch for us.

Cynthgob profile image
Cynthgob in reply toKat95

Thank u

Drcrunch profile image
Drcrunch in reply toKat95

Did he have parp inhibitor by itself or combined with chemo. Which parp inhibitor?

Kat95 profile image
Kat95 in reply toDrcrunch

Hi it was niraparib.

Not what you're looking for?

You may also like...

25 Somatic Gene Mutations!

Hello everyone, It's been a couple of months. My dad, newly diagnosed with metastasized PC, has...

2017 John Hopkins Study "sheds light on why cancer often strikes those with healthy lifestyles"

by Vanessa Wasta Most cancer mutations are due to random DNA copying 'mistakes,' not inherited or...
diamondrn profile image

TMI Overload Paralysis , ATM gene defect, and its BT radiation therapy in 10 days.

So all scheduled for BT therapy(90 days post DX with gleason 9, 15 PSA, & lymph involvement). Just...
sammamish profile image

Update after oncology visit

MO offered us a trial of olaparib in combination with AZD6738 . Husband did not have braca or any...
Dalipup profile image

Moderation team

Bethishere profile image
BethishereAdministrator
Number6 profile image
Number6Administrator
Darryl profile image
DarrylPartner

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.